Sage Inks Publishing Deal with Causaly’s AI Platform Focusing on Drug Discovery Research

Summary

Sage and Causaly announced a publishing partnership to integrate full-text peer-reviewed scientific literature into Causaly's AI-powered drug discovery platform. This marks Causaly's first partnership with a major scientific, technical, and medical (STM) publisher.